Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

AKRO holding history

Akero Therapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AKRO overviewAll 13F holders of AKROFull Q4 2025 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of AKRO by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−4,526,920−100.0%Sold outHolders
Q3 20254,526,920$214.9M<0.1%−2,708−0.1%ReducedHolders
Q2 20254,529,628$241.7M<0.1%+298,984+7.1%AddedHolders
Q1 20254,230,644$171.3M<0.1%+526,233+14.2%AddedHolders
Q4 20243,704,411$103.1M<0.1%+27,830+0.8%AddedHolders
Q3 20243,676,581$105.5M<0.1%−28,509−0.8%ReducedHolders
Q2 20243,705,090$86.9M<0.1%+35,167+1.0%AddedHolders
Q1 20243,669,923$92.7M<0.1%+584,875+19.0%AddedHolders
Q4 20233,085,048$72.0M<0.1%+72,866+2.4%AddedHolders
Q3 20233,012,182$152.4M<0.1%+326,308+12.1%AddedHolders
Q2 20232,685,874$125.4M<0.1%+546,981+25.6%AddedHolders
Q1 20232,138,893$81.8M<0.1%+22,322+1.1%AddedHolders
Q4 20222,116,571$116.0M<0.1%+375,978+21.6%AddedHolders
Q3 20221,740,593$59.3M<0.1%+429,579+32.8%AddedHolders
Q2 20221,311,014$12.4M<0.1%+84,103+6.9%AddedHolders
Q1 20221,226,911$17.4M<0.1%+56,492+4.8%AddedHolders
Q4 20211,170,419$24.8M<0.1%+89,834+8.3%AddedHolders
Q3 20211,080,585$24.2M<0.1%+20,949+2.0%AddedHolders
Q2 20211,059,636$26.3M<0.1%+73,916+7.5%AddedHolders
Q1 2021985,720$28.6M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.